Back
Dynex Capital, Inc. 10K Form
Buy
56
DX
Dynex Capital, Inc.
Last Price:
$14.08
Seasonality Move:
4.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-26 | 10Q | DX/Dynex Capital, Inc. Quarterly |
| 2023-11-06 | 10Q | DX/Dynex Capital, Inc. Quarterly |
| 2023-07-28 | 10Q | DX/Dynex Capital, Inc. Quarterly |
| 2023-04-28 | 10Q | DX/Dynex Capital, Inc. Quarterly |
| 2022-10-31 | 10Q | DX/Dynex Capital, Inc. Quarterly |
| 2022-08-01 | 10Q | DX/Dynex Capital, Inc. Quarterly |
Receive DX News And Ratings
See the #1 stock for the next 7 days that we like better than DX
DX Financial Statistics
Sales & Book Value
| Annual Sales: | $420.4M |
|---|---|
| Cash Flow: | $68.3M |
| Price / Cash Flow: | 12.69 |
| Annual Sales: | $13.47 |
| Price / Book: | 1.19 |
Profitability
| EPS (TTM): | 2.03850 |
|---|---|
| Net Income (TTM): | $319.1M |
| Gross Margin: | $420.4M |
| Return on Equity: | 18.53% |
| Return on Assets: | 2.66% |
Dynex Capital, Inc. Earnings Forecast
Key Dynex Capital, Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for DX is 100.00%.
-
The Selling, General & Administrative Expenses for DX have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 131.37% of Operating Income.
-
The Net Earning history of DX is 75.89% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 18 years.
Dynex Capital, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Mortgage Real Estate Investment Trusts (REITs) |
| Sector: | Financials |
| Current Symbol: | DX |
| CUSIP: | 26817Q |
| Website: | dynexcapital.com |
Debt
| Debt-to-Equity Ratio: | 5.65 |
|---|---|
| Current Ratio: | 0.07 |
| Quick Ratio: | 0.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.7 |
|---|---|
| Forward P/E Ratio: | 10.16 |
DX Technical Analysis vs Fundamental Analysis
Buy
56
Dynex Capital, Inc. (DX)
is a Buy
Is Dynex Capital, Inc. a Buy or a Sell?
-
Dynex Capital, Inc. stock is rated a BuyThe current Dynex Capital, Inc. [DX] share price is $14.07. The Score for DX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.